Azole resistance in Aspergillus fumigatus: a growing public health concern

Edith Vermeulen1, Katrien Lagrou, Paul E Verweij

  • 1aDepartment of Microbiology and Immunology, Catholic University of Leuven bDepartment of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium cDepartment of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.

Abstract

Insights

Azole resistance in Aspergillus fumigatus is a growing global health concern. Environmental and patient-derived resistant strains, like TR34/L98H, are increasingly reported worldwide, necessitating further research and data collection.

Area of Science:

  • Medical Mycology
  • Antimicrobial Resistance
  • Fungal Pathogenesis

Background:

  • Azole resistance in Aspergillus fumigatus emerged as a significant clinical concern in the late 2000s.
  • Both chronically treated and azole-naive patients are at risk due to resistant environmental strains.
  • Understanding the origin and evolution of resistance is crucial for managing invasive fungal infections.

Purpose of the Study:

  • To review the latest findings on the origin, evolution, and implications of azole resistance in Aspergillus fumigatus.
  • To highlight the increasing prevalence and geographical spread of resistant strains.
  • To discuss emerging resistance mechanisms and the need for better data management.

Main Methods:

  • Literature review of recent epidemiological and molecular studies on azole resistance in A. fumigatus.
  • Analysis of reported resistance mechanisms, including CYP51A-mediated and non-CYP51A-mediated pathways.
  • Synthesis of data on the geographical distribution and genotypic variations of resistant isolates.

Main Results:

  • TR34/L98H is the predominant environmental resistance mechanism, with expanding reports globally.
  • Genotypic differences exist between Middle Eastern and European TR34/L98H strains, suggesting independent emergence.
  • A novel environmental resistance mechanism, TR46/Y121F/T289A, confers voriconazole resistance.
  • Patient resistance mechanisms are diversifying beyond CYP51A-mediated pathways.

Conclusions:

  • Azole resistance in Aspergillus fumigatus is a rapidly evolving global health problem.
  • Continuous monitoring and characterization of resistant strains are essential.
  • Centralized registration of treatment and outcome data for patients with resistant aspergillosis is needed.

Related Concept Videos

Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
2.4K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
787
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
2.1K
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
132